Psilocybin for major depression granted Breakthrough Therapy by FDA

Magic Mushroom Drug Lifts Depression in Human Trial

Psilocybin shows higher remission rate than SSRI drugs in a U.K. study

The Push to Legalize Magic Mushrooms for Depression and PTSD

Activists, entrepreneurs, and doctors in the US and Canada are working to decriminalize psilocybin psychotherapy and calling for a psychedelic revolution.

From treating PTSD to quitting tobacco: researchers say public investment into psychedelic drugs essential | CBC News

Magic mushrooms to treat depression, ecstasy to cure PTSD and LSD to combat alcoholism; just some of the drug-affliction pairings that have been tested in recent years.

A Dose of a Hallucinogen From a ‘Magic Mushroom,’ and Then Lasting Peace (Published 2016)

Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.

Leading Innovation in Psychiatric Treatment | Alto Neuroscience

We leverage brain biology to develop personalized medicines, helping patients get better faster.

PTAB Affirms §101 Rejection of Psilocybin Composition, Post-Appeal Prosecution Results in Granted Patent

PTAB Finds that Psilocybin Formulation Is Not a Product of Nature, Further Prosecution Leads to Issued Patent

Researchers are giving religious leaders psychedelic drugs in the interest of science

Despite the fact that psychedelic drugs have been used for millennia as medicine in ritualistic ceremonies, there remain many questions in the scientific community about the relationship between their spiritual qualities and healing potential. Researchers at Johns Hopkins and New York Universities are giving psilocybin, the active ingredient in magic mushrooms, to ordained ministers in the hopes that they can help provide some answers.

FDA Designates MDMA As 'Breakthrough Therapy' For Post-Traumatic Stress

The drug, often used recreationally in the form of ecstasy, has been found to offer a potentially significant advantage over extant treatments for the disorder.

Scientists push to renew psychedelic drug research for psychiatry

Back in the 50's there were legitimate medical experiments with LSD but psychedelic drugs in the labs were side-swiped by their use on the street. And as a growing counter-culture dropped acid, governments picked up restrictions making research almost impossible. Until now.

A single high dose of psilocybin alters brain function up to one month later

New research provides evidence that the active ingredient in so-called magic mushrooms can affect brain processes related to emotional functioning long

What Happens When Clergy Take Psilocybin

The results of a controversial 10-year-old study of more than a dozen clergy who took psilocybin on guided trips only recently came to light.

Mushrooms evolved psychedelics twice, baffling scientists

Researchers found that magic mushrooms and fiber caps independently evolved different biochemical pathways to create psilocybin. This convergence shows nature’s ingenuity, but the reason why remains unknown—possibly predator deterrence. Beyond evolutionary mystery, the discovery provides new enzyme tools for biotech, with promising applications for producing psilocybin-based medicines.

Growing research finds psychedelics effective in treating disease

Gordon McGlothlin, who took his first puff at age 12 behind his family’s garage, tried to quit smoking for years, but no cessation technique worked until he used a psychedelic drug. Researchers with the Johns Hopkins University…

Flashback! Psychedelic research returns

Four decades after Timothy Leary, LSD shows success in medical trials. Will the right completely trip?

Sanitizing the Psychedelic Revolution

Big Pharma is rushing to monetize ancient healing practices, but what’s left might not be the same medicine